Biotech vet Troy Wilson shines a spotlight on his oligonucleotide startup as Eli Lilly signs up for a premier Big Pharma partnership
Troy Wilson is best known now for his role leading Kura Oncology, where the team has been developing targeted cancer drugs. Not so well known …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
